BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2017 6:20:00 PM | Browse: 1127 | Download: 2099
 |
Received |
|
2016-12-12 09:49 |
|
Peer-Review Started |
|
2016-12-12 10:40 |
|
To Make the First Decision |
|
2016-12-19 11:13 |
|
Return for Revision |
|
2016-12-20 11:06 |
|
Revised |
|
2016-12-29 10:09 |
|
Second Decision |
|
2017-01-06 15:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2017-01-11 11:56 |
|
Articles in Press |
|
2017-01-11 11:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2017-01-15 21:32 |
|
Typeset the Manuscript |
|
2017-01-20 11:08 |
|
Publish the Manuscript Online |
|
2017-02-26 18:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian-Hai Guo, Hang-Yu Zhang, Song Gao, Peng-Jun Zhang, Xiao-Ting Li, Hui Chen, Xiao-Dong Wang and Xu Zhu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Capital Medical Development and scientific research fund, China |
2014-2-2154 |
|
| Corresponding Author |
Xu Zhu, MD, Chief, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Interventional therapy, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing 100142, China. drzhuxu@163.com |
| Key Words |
Liver metastasis; Hepatic artery infusion chemotherapy; Raltitrexed; Colorectal cancer; FOLFOX |
| Core Tip |
Our study shows that hepatic artery infusion chemotherapy (HAIC) with either TOMOX (oxaliplatin plus raltitrexed) or FOLFOX (oxaliplatin plus 5-fluorouracil) was proven to be an efficient and safe alternative choice for patients with chemotherapy refractory colorectal cancer liver metastasis and no significant difference in survival was found between these two treatments. Cox univariate analysis shows that response to HAIC was a significant predictive factor. |
| Publish Date |
2017-02-26 18:20 |
| Citation |
Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World J Gastroenterol 2017; 23(8): 1406-1411 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i8/1406.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i8.1406 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
